ESC 365 - Inflammatory biomarkers: why measure hsCRP as well as LDL?

Open Access

Inflammatory biomarkers: why measure hsCRP as well as LDL?

Session: Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance

Topic: Inflammation

Speaker: Doctor P. Ridker (Boston, US)

Sponsored by Novo Nordisk

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

42 presentations

9 followers

4 more presentations in this session

Why are we here?

Speaker: Professor R. Mehran (New York, US)

Targeting inflammation in acute myocardial infarction: what, when, who?

Speaker: Doctor C. Matter (Zurich, CH)

Inflammation management in ASCVD and AMI: what the clinical guidelines say

Speaker: Professor F. Andreotti (Rome, IT)

Summary, Q&A and close

Access the full session

Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance

Speakers: Doctor P. Ridker, Professor R. Mehran, Doctor C. Matter, Professor F. Andreotti

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources